|Bid||67.75 x 800|
|Ask||67.84 x 1100|
|Day's Range||67.67 - 69.72|
|52 Week Range||44.79 - 90.19|
|Beta (5Y Monthly)||0.56|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 05, 2021 - May 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||97.23|
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on April 15, 2021, the Compensation Committee of its Board of Directors granted to 17 new employees inducement stock options to purchase an aggregate of 50,785 shares of its common stock and 20,490 inducement restricted stock units ("RSUs"). The inducement stock options and RSUs have a grant date and vesting commencement date of April 15, 2021 and were granted as inducements material to the new employees entering employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).
With the fourth-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the first quarter of 2021. One of these stocks was Arena Pharmaceuticals, Inc. (NASDAQ:ARNA). Is ARNA stock a […]
Arena Pharmaceuticals, Inc. (ARNA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.